EspeRare

Industry / private company


Location: Genève, Switzerland (CH) CH

ISNI: -

ROR: https://ror.org/04jqjaf29

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia (2023) Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Norton ME, Cavalli R, et al. Journal article Natural history of X-linked hypohidrotic ectodermal dysplasia: a 5-year follow-up study (2020) Wohlfart S, Meiller R, Hammersen J, Park J, Menzel-Severing J, Melichar VO, Huttner K, et al. Journal article Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement (2020) Sagar R, Almeida-Porada G, Blakemore K, Chan JK, Choolani M, Götherström C, Jaulent A, et al. Journal article, Review article Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects (2020) Körber I, Klein OD, Morhart P, Faschingbauer F, Grange DK, Clarke A, Bodemer C, et al. Journal article